
Medannex’s new therapy shows powerful synergy with common cancer treatments
Medannex Ltd (Edinburgh) announced on 10th December 2021 the latest data on their new targeted agent, MDX-124, demonstrating significant anti-cancer...
Do you have news for the Scottish Life Sciences Community?
Submit Your Own News